- TRADE NAME: Diprivan (AstraZeneca)
- INDICATIONS: Induction and maintenance of anesthesia
- CLASS: Anesthetic; general
- HALF-LIFE: initial: 40 minutes; terminal: 3 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Zinc
Please login to view the rest of this drug profile.
Page last updated 04/08/2025